Maynard Um
-
-
-
-
-
-
-
Anixa ovarian cancer CAR-T trial advances to fifth dose cohort
-
-
-
-
-
-
-
Anixa gets approval to increase CAR-T doses up to 100x in cancer trial
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)
-
-
-
-
-
-
-
Anixa Biosciences (ANIX) Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
-
-
-
-
-
-
-
Anixa Biosciences (ANIX) Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
-
-
-
-
-
-
-
Anixa Biosciences (ANIX) Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
-
-
-
-
466,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


